X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global Guillain-Barre Syndrome Companies

This report lists the top Global Guillain-Barre Syndrome companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Guillain-Barre Syndrome industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Global Guillain-Barre Syndrome Top Companies

  1. CSL Behring

  2. Takeda Pharmaceuticals

  3. Grifols

  4. Kedrion Biopharma

  5. Octapharma

*Disclaimer: Top companies sorted in no particular order

Global Guillain-Barre Syndrome Market Major Players

Global Guillain-Barre Syndrome Market Concentration

Global Guillain-Barre Syndrome  Market Concentration

Global Guillain-Barre Syndrome Company List

                              • CSL Limited

                              • Takeda Pharmaceutical Company Limited

                              • Grifols S A

                              • Octapharma AG

                              • Bayer AG

                              • Kedrion Biopharma Inc

                              • China Biologic Products Holdings Inc

                              • Biotest AG

                              • Annexon Inc.

                              • Cellenkos inc.


                          Specific to Global Guillain-Barre Syndrome Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Guillain-Barre Syndrome Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)